Advanced Imaging Analytics (RadGap)
AI-enabled image and report analytics to help close care gaps
Company profile
Company profile
Imagen Technologies, Inc. is transforming diagnostic imaging by creating a new standard of care that combines first-of-its-kind AI technology with world-class clinical expertise. The company provides comprehensive diagnostic imaging solutions including permanent in-office imaging equipment and programs, AI-enabled sub-specialized specialist interpretations by U.S.-based board-certified radiologists, and advanced imaging analytics (RadGap) to help payers, providers, and risk-bearing entities close care gaps. Founded by CEO Alex Dresner based on personal experiences with diagnostic imaging error, Imagen's mission is to ensure every patient receives the right diagnosis at the right time. The company operates across 23 states with radiologist licenses in all 50 states, serving 3.5 million patients through 200+ clinic locations. Their vertically integrated approach combines FDA-cleared deep-learning-based Computer Assisted Detection software with 95+ board-certified specialists and sub-specialists, delivering 24/7 high-quality teleradiology support. Imagen's proprietary AI technology has demonstrated significant clinical impact, including a 73% reduction in life-threatening clinical misses and 100% increase in appropriate chronic disease identification. The company maintains a 97% all-time customer retention rate and 95% physician recommendation rate, reflecting their commitment to partnership and quality. Their technology is built on one of the largest medical imaging datasets in the world, with tens of millions of images, and has undergone rigorous FDA evaluation and peer-reviewed publication in journals such as PNAS and Nature Digital Medicine.
Company description Imagen Technologies, Inc official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Cloud Saas · Embedded · On Premise deployment with recorded integration context.
Recorded integration context: EMR systems.
Company milestones
Operating in 23 states, serving 3.5 million patients through 200+ clinic locations, 1.3 million+ run-rate annual diagnostic results provided, radiologist licenses across all 50 states
Partnerships
No partners are currently listed.
02 · Flagship portfolio
Selected source-backed Company products and the available commercial context.
AI-enabled image and report analytics to help close care gaps
FDA-cleared AI algorithms to support diagnostic specialists
FDA-cleared AI algorithms for enhanced diagnostic accuracy
U.S.-based, board-certified specialists enabled with cutting-edge AI for improved accuracy
Permanent, in-office imaging equipment and programs with end-to-end support
AI-enabled image and report analytics that help close care gaps
03 · Research intelligence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
No linked records are currently available.
Clinical validation
No linked records are currently available.
Regulatory
K230085 · 510k · Oct 3, 2023
Lung-CADK223811 · 510k · Sep 13, 2023
Aorta-CADK213353 · 510k · Sep 20, 2022
Chest-CADK210666 · 510k · Jul 20, 2021
FractureDetect (FX)K193417 · 510k · Jul 30, 2020
OsteoDetectDEN180005 · De Novo · May 24, 2018
04 · Company-reported outcomes
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Based on clinical research for Chest-CAD
Based on Imagen customer impact
Provider satisfaction
Customer satisfaction
Patient experience
Customer growth
Improved chronic disease identification through AI-enabled imaging analytics
100% increase in appropriate chronic disease identification
Reducing life-threatening clinical misses and improving chronic disease identification through AI-enabled diagnostic imaging
73% reduction of life-threatening clinical misses and 100% increase in appropriate chronic disease identification
Delivering rapid, high-quality diagnostic imaging services with AI-enabled specialist interpretations
95% of physicians would recommend Imagen to other physicians, 97% all-time customer retention rate, 96% patient satisfaction rate
05 · Leadership
Leadership profiles and professional links from the current Company record.
Alex Dresner
CEO & Founder
06 · Company updates
Recent articles published on Imagen Technologies, Inc's official website.
07 · HAIC coverage
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Curated official destinations from the active Company record.
09 · Market pathway
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Companies that apply AI to analyze medical images for diagnostic purposes, workflow optimization, or clinical decision support. Covers general radiology (X-rays, CT scans, MRIs, ultrasounds) across multiple organ systems, as well as specialized imaging in ophthalmology and dermatology.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.